Archives
Review: Perioperative venous thromboembolism prophylaxis
3 Dec, 2020 | 08:28h | UTCPerioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer
2 Dec, 2020 | 07:31h | UTC
What’s the difference between viral shedding and reinfection with COVID-19?
2 Dec, 2020 | 07:29h | UTCWhat’s the difference between viral shedding and reinfection with COVID-19? – The Conversation
Opinion: “Put an end to publication by proclamation for Covid vaccines”
2 Dec, 2020 | 07:27h | UTCPut An End To Publication By Proclamation For Covid Vaccines – Forbes
One in five covid-19 patients are diagnosed with a mental illness within three months
2 Dec, 2020 | 07:24h | UTC
Commentary on Twitter
https://twitter.com/TheLancetPsych/status/1326158490423996417
CDC panel moves health workers, nursing home residents to front of COVID vaccine line
2 Dec, 2020 | 07:26h | UTCCDC panel moves health workers, nursing home residents to front of COVID vaccine line – CIDRAP
Two meta-analysis find ethnic minorities disproportionately affected by coronavirus
2 Dec, 2020 | 07:22h | UTCMeta-analysis 1: Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths: A Systematic Review – Annals of Internal Medicine
Meta-analysis 2: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis – EClinicalMedicine
Commentary: Ethnic minorities disproportionately affected by coronavirus, meta-study finds – Reuters
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019. At least one in every three people in the world needs rehabilitation at some point in the course of their illness or injury
2 Dec, 2020 | 07:17h | UTC
Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”
2 Dec, 2020 | 07:19h | UTC
Commentary on Twitter
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review https://t.co/lmWQNgpIfd Existing evidence supports the wide-held belief that the the risk of #SARSCoV2 transmission is lower outdoors (< 10%).
— Carlos del Rio (@CarlosdelRio7) December 1, 2020
IDSA 2020 Guidelines for the prevention, diagnosis and treatment of Lyme disease
1 Dec, 2020 | 08:28h | UTC
Randomized trial: A low-fat vegan diet can reduce body weight and improve insulin sensitivity in overweight adults
2 Dec, 2020 | 07:16h | UTCCommentary: Plant-based diet ramps up metabolism, according to new study – Physicians Committee for Responsible Medicine
WHO World malaria report 2020: 20 years of global progress & challenges
1 Dec, 2020 | 08:27h | UTCWorld malaria report 2020: 20 years of global progress & challenges – World Health Organization
News Release: WHO calls for reinvigorated action to fight malaria
Review: Hearing loss in children
2 Dec, 2020 | 07:14h | UTCHearing Loss in Children: A Review – JAMA (free for a limited period)
Author interview: Hearing Loss in Children
Cohort study: Higher dose Z-drug use in dementia is associated with increased fracture and stroke risks, similar or greater to that for higher dose benzodiazepines
1 Dec, 2020 | 08:25h | UTCCommentary: The danger of Z-drugs for dementia patients – University of Exeter
NICE COVID-19 guideline: Prevention of thromboembolism in patients with COVID-19. “For patients who are having advanced respiratory support: consider increasing pharmacological VTE prophylaxis to an intermediate dose”
1 Dec, 2020 | 08:19h | UTC
Moderna released more Covid-19 vaccine results. They’re very encouraging.
1 Dec, 2020 | 08:15h | UTCModerna released more Covid-19 vaccine results. They’re very encouraging. – Vox
Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy – STAT AND More Good News For Moderna’s COVID-19 Vaccine Candidate – NPR AND Moderna to seek emergency authorization for COVID-19 vaccine – CIDRAP
Commentary on Twitter
Moderna has announced the final results of the 30,000-person efficacy trial for its #COVID19 vaccine candidate, reporting that the vaccine had 100% efficacy against severe disease. https://t.co/Cgg0I5nv9r
— News from Science (@NewsfromScience) November 30, 2020
Comprehensive review on the management of pharmaceutical and recreational drug poisoning
1 Dec, 2020 | 08:21h | UTCManagement of pharmaceutical and recreational drug poisoning – Annals of Intensive Care
Opinion: How Prestige Journals Remain Elite, Exclusive and Exclusionary. “by announcing a €9,500 price tag, Nature has failed to enact their own diversity and inclusion pledge”
1 Dec, 2020 | 08:22h | UTCHow Prestige Journals Remain Elite, Exclusive And Exclusionary – Forbes
See also: For €9500, Nature journals will now make your paper free to read
Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data
1 Dec, 2020 | 08:13h | UTC
Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial
1 Dec, 2020 | 08:08h | UTCCommentary: Gout drug Colchicine to be tested as COVID-19 treatment in UK trial – Reuters
Critically ill patients with COVID-19: A narrative review on prone position
1 Dec, 2020 | 08:07h | UTCCritically Ill Patients with COVID-19: A Narrative Review on Prone Position – Pulmonary Therapy
The Ioannidis affair: A tale of major scientific overreaction
1 Dec, 2020 | 08:10h | UTCThe Ioannidis Affair: A Tale of Major Scientific Overreaction – Scientific American
The COVID science wars: Shutting down scientific debate is hurting the public health
1 Dec, 2020 | 08:11h | UTCThe COVID Science Wars – Scientific American
Report: SARS-CoV-2 setting-specific transmission rates. Households showed the highest transmission rates (21.1%). Asymptomatic infections do occur but much less efficiently than symptomatic infection.
30 Nov, 2020 | 01:01h | UTCFull report: SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis – Imperial College London
AstraZeneca vaccine most attractive option for Africa, says WHO – Astra Zeneca CEO says company will run new trial to test more efficient dose
1 Dec, 2020 | 08:05h | UTC